» Articles » PMID: 7511675

Structure and Function of Decay Accelerating Factor CD55

Overview
Journal J Lab Clin Med
Publisher Elsevier
Date 1994 Apr 1
PMID 7511675
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Studies of decay-accelerating factor (DAF) function and structure are reviewed. DAF was first recognized as a species restricting factor operating at the level of C3/C5 activation. Cloning of the gene indicates that DAF has four short consensus repeats of the type characteristic of the regulators of complement activation gene cluster family. The third short consensus repeat is responsible for DAF's complement regulatory activity and signaling. DAF, like other glycophosphatidylinositol (GPI) anchored proteins, is associated with tyrosine kinases, and these kinases are probably the signaling devices. The details of how DAF's GPI anchor in the outer leaflet of plasma membrane connects with the tyrosine kinases on the inner leaflet are not known. Although DAF does not have an essential role in controlling hemolysis of erythrocytes, it does have important role in regulating the deposition of C3 on nucleated cells. The therapeutic potential of DAF is discussed.

Citing Articles

Immune transcriptomic profile in adult female pigs: dominance status has more influence than environmental enrichment.

Lopes M, Clouard C, Vincent A, Thomas F, Herault F, Louveau I BMC Genomics. 2024; 25(1):1211.

PMID: 39695383 PMC: 11657968. DOI: 10.1186/s12864-024-11116-1.


Why nature evolved GPI-anchored proteins: unique structure characteristics enable versatile cell surface functions.

Zhang Q, Fujita M Glycobiology. 2024; 34(12).

PMID: 39530348 PMC: 11632373. DOI: 10.1093/glycob/cwae089.


The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.

Avdonin P, Blinova M, Generalova G, Emirova K, Avdonin P Biomolecules. 2024; 14(1).

PMID: 38254639 PMC: 10813406. DOI: 10.3390/biom14010039.


Labeling cell surface glycosylphosphatidylinositol-anchored proteins through metabolic engineering using an azide-modified phosphatidylinositol.

Kundu S, Jaiswal M, Craig K, Guo J, Guo Z Biochem Biophys Res Commun. 2023; 645:103-109.

PMID: 36682329 PMC: 9899547. DOI: 10.1016/j.bbrc.2023.01.029.


Silencing EGFR-upregulated expression of CD55 and CD59 activates the complement system and sensitizes lung cancer to checkpoint blockade.

Shao F, Gao Y, Wang W, He H, Xiao L, Geng X Nat Cancer. 2022; 3(10):1192-1210.

PMID: 36271172 DOI: 10.1038/s43018-022-00444-4.